Assembly Biosciences Stock Price - ASMB

0.00 (0.00%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Assembly Biosciences Inc ASMB NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.76 -3.59% 20.42 20.20 21.4659 21.25 21.18 19:59:36
Bid Price Ask Price Spread Spread % News
16.50 22.00 5.50 25.0% 3 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,248 189,416 $ 20.77 $ 3,933,584 299,235 8.1301 - 25.07
Last Trade Time Type Quantity Stock Price Currency
15:59:41 formt 110 $ 20.42 USD

Assembly Biosciences Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 660.28M 32.33M $ -90.75M -4.00 - 30.20M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 4.00 6.60%

more financials information »

Assembly Biosciences News

Loading Messages....

Latest ASMB Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ASMB Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week19.6521.3919.36120.58311,1100.773.92%
1 Month17.9221.3916.2318.54279,2502.5013.95%
3 Months13.9725.0713.7120.15456,7116.4546.17%
6 Months12.6025.078.130116.29510,4017.8262.06%
1 Year23.8825.078.130116.27403,134-3.46-14.49%
3 Years19.8067.368.130124.72237,3200.623.13%
5 Years10.3867.364.3322.88167,19210.0496.72%

Assembly Biosciences Description

Assembly Biosciences Inc is a clinical stage biotechnology company. It is advancing two innovative platform programs, a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein.

Your Recent History
Assembly B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.